Litcius/Paper detail

Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial

Omuro, Antonio, Brandes, Alba A, Carpentier, Antoine F, Idbaih, Ahmed, Reardon, David A, et al, Roth, Patrick, Weller, Michael

2023Open MIND15 citations

Topics & Concepts

TemozolomideNivolumabMedicineOncologyRadiation therapyInternal medicineGlioblastomaRandomized controlled trialPhases of clinical researchO-6-methylguanine-DNA methyltransferaseChemoradiotherapyDacarbazineClinical trialChemotherapyAdverse effectPhase (matter)MEDLINEGlioma Diagnosis and TreatmentBrain Metastases and TreatmentNeuroblastoma Research and Treatments
Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial | Litcius